627 related articles for article (PubMed ID: 33168071)
21. Attenuation of aquaporin-3 and epidermal growth factor receptor expression and activation in systemic sclerosis dermal fibroblasts.
Farhadi E; Mahmoudi M; Rahmani F; Yousefi B; Sarafnejad A; Kavosi H; Karimizadeh E; Jamshidi A; Gharibdoost F
J Cell Physiol; 2019 Aug; 234(8):12876-12883. PubMed ID: 30536805
[TBL] [Abstract][Full Text] [Related]
22. A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies.
Yasuoka H; Ihn H; Medsger TA; Hirakata M; Kawakami Y; Ikeda Y; Kuwana M
J Immunol; 2003 Dec; 171(12):6883-90. PubMed ID: 14662895
[TBL] [Abstract][Full Text] [Related]
23. [Transdifferentiation of fibroblasts into myofibroblasts in the skin lesion of systemic sclerosis: role of transforming growth factor β1 and its signal transduction].
Liu T; Hu XD
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1840-5. PubMed ID: 22126761
[TBL] [Abstract][Full Text] [Related]
24. T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts
Vettori S; Barra G; Russo B; Borgia A; Pasquale G; Pellecchia L; Vicedomini L; De Palma R
Front Immunol; 2020; 11():220. PubMed ID: 32174912
[No Abstract] [Full Text] [Related]
25. [Effects of Wenyang Huazhuo Tongluo Recipe Containing Serum on Transforming Growth Factor β1/ Smad Signaling Pathway of Skin Fibroblasts in Systemic Sclerosis].
Bian H; Lv Q; Huang XZ; Hu JL; Yang L; Mao BY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1054-9. PubMed ID: 26591358
[TBL] [Abstract][Full Text] [Related]
26. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
[TBL] [Abstract][Full Text] [Related]
27. Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway.
Shen C; Jiang Y; Li Q; Liu C; Hu F; Li M
J Dermatol Sci; 2021 Aug; 103(2):82-92. PubMed ID: 34266726
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-beta pathway to recapitulate the "scleroderma phenotype".
Zhou X; Tan FK; Milewicz DM; Guo X; Bona CA; Arnett FC
J Immunol; 2005 Oct; 175(7):4555-60. PubMed ID: 16177099
[TBL] [Abstract][Full Text] [Related]
29. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
30. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of RXFP1 receptor contributes to the inefficacy of relaxin-based anti-fibrotic treatments in systemic sclerosis.
Corallo C; Pinto AM; Renieri A; Cheleschi S; Fioravanti A; Cutolo M; Soldano S; Nuti R; Giordano N
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):69-75. PubMed ID: 31365333
[TBL] [Abstract][Full Text] [Related]
32. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
33. DNA from macrophages induces fibrosis and vasculopathy through POLR3A/STING/type I interferon axis in systemic sclerosis.
Liu C; Tang J; Luo W; Liu S; Sun X; Hong W; Zhou X; Lu J; Li M; Zhu L
Rheumatology (Oxford); 2023 Feb; 62(2):934-945. PubMed ID: 35686918
[TBL] [Abstract][Full Text] [Related]
34. dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts.
Farina G; York M; Collins C; Lafyatis R
Ann Rheum Dis; 2011 Mar; 70(3):544-50. PubMed ID: 21068089
[TBL] [Abstract][Full Text] [Related]
35. The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist.
Cipriani P; Di Benedetto P; Ruscitti P; Capece D; Zazzeroni F; Liakouli V; Pantano I; Berardicurti O; Carubbi F; Pecetti G; Turricchia S; Alesse E; Iglarz M; Giacomelli R
J Rheumatol; 2015 Oct; 42(10):1808-16. PubMed ID: 26276964
[TBL] [Abstract][Full Text] [Related]
36. Fibrosis and immune dysregulation in systemic sclerosis.
Chizzolini C; Brembilla NC; Montanari E; Truchetet ME
Autoimmun Rev; 2011 Mar; 10(5):276-81. PubMed ID: 20863906
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells.
Simon M; Lücht C; Hosp I; Zhao H; Wu D; Heidecke H; Witowski J; Budde K; Riemekasten G; Catar R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769227
[TBL] [Abstract][Full Text] [Related]
38. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
[TBL] [Abstract][Full Text] [Related]
39. Autoantibody profiles in systemic sclerosis; a comparison of diagnostic tests.
Alkema W; Koenen H; Kersten BE; Kaffa C; Dinnissen JWB; Damoiseaux JGMC; Joosten I; Driessen-Diks S; van der Molen RG; Vonk MC; Smeets RL
Autoimmunity; 2021 May; 54(3):148-155. PubMed ID: 33818234
[TBL] [Abstract][Full Text] [Related]
40. Toll-like Receptor 9 Signaling Is Augmented in Systemic Sclerosis and Elicits Transforming Growth Factor β-Dependent Fibroblast Activation.
Fang F; Marangoni RG; Zhou X; Yang Y; Ye B; Shangguang A; Qin W; Wang W; Bhattacharyya S; Wei J; Tourtellotte WG; Varga J
Arthritis Rheumatol; 2016 Aug; 68(8):1989-2002. PubMed ID: 26946325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]